Quantitative low-volume assay for simultaneous determination of fentanyl, norfentanyl, and minor metabolites in human plasma and urine by liquid chromatography—tandem mass spectrometry (LC-MS/MS)

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Zeitschrift für Rechtsmedizin

• Publication date

  2014-07-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00414-014-1040-yPMID 24997532
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fentanyl Pharmacokinetics is not Dependent on Hepatic Uptake by Organic Anion‐Transporting Polypeptide 1B1 in Human Beings

  2013cited by this paper
• Oxford Textbook of Endocrinology and Diabetes (2nd edn)

  2012cited by this paper
• Transdermal Patch : Postmortem Tissue Distribution of Fentanyl in 25 Cases

  2012cited by this paper
• Fentanyl: toxic or therapeutic? Postmortem and antemortem blood concentrations after transdermal fentanyl application.

  2012cited by this paper
• Determination of fentanyl, metabolite and analogs in urine by GC/MS

  2011cited by this paper
• A low blood volume LC-MS/MS assay for the quantification of fentanyl and its major metabolites norfentanyl and despropionyl fentanyl in children.

  2011cited by this paper
• Development and validation of a sensitive ultra performance liquid chromatography tandem mass spectrometry method for the analysis of fentanyl and its major metabolite norfentanyl in urine and whole blood in forensic context.

  2010cited by this paper
• A comprehensive LC-MS-based quantitative analysis of fentanyl-like drugs in plasma and urine.

  2010cited by this paper
• The use of in vitro technologies coupled with high resolution accurate mass LC-MS for studying drug metabolism in equine drug surveillance.

  2010cited by this paper
• Development of a liquid chromatography-isotope dilution mass spectrometry method for quantification of fentanyl in human plasma.

  2009cited by this paper
• Report of a patient chewing fentanyl patches who was titrated onto methadone

  2009cited by this paper
• Fatal outcome in a child after ingestion of a transdermal fentanyl patch

  2007cited by this paper
• LC-MS/MS analysis of fentanyl and norfentanyl in a fatality due to application of multiple Durogesic transdermal therapeutic systems.

  2007cited by this paper
• Fatalities Associated with Fentanyl and Co‐administered Cocaine or Opiates

  2007cited by this paper
• Direct-injection mass spectrometric method for the rapid identification of fentanyl and norfentanyl in postmortem urine of six drug-overdose cases.

  2007cited by this paper
• Pharmacokinetics, Tolerability, and Performance of a Novel Matrix Transdermal Delivery System of Fentanyl Relative to the Commercially Available Reservoir Formulation in Healthy Subjects

  2006cited by this paper
• Drug Abuse Handbook

  2006cited by this paper
• An automated and fully validated LC-MS/MS procedure for the simultaneous determination of 11 opioids used in palliative care, with 5 of their metabolites.

  2006cited by this paper
• Determination of fentanyl in human plasma and fentanyl and norfentanyl in human urine using LC-MS/MS.

  2005cited by this paper
• Analysis of amphetamines and fentanyls by atmospheric pressure desorption/ionization on silicon mass spectrometry and matrix-assisted laser desorption/ionization mass spectrometry and its application to forensic analysis of drug seizures.

  2005cited by this paper
• Bioanalytical Method Validation

  2004cited by this paper
• Simultaneous extraction and quantitation of fentanyl and norfentanyl from primate plasma with LC/MS detection.

  2004cited by this paper
• Urine concentrations of fentanyl and norfentanyl during application of Duragesic transdermal patches.

  2004cited by this paper
• Fatal intravenous fentanyl abuse: four cases involving extraction of fentanyl from transdermal patches.

  2004cited by this paper
• Analysis of fentanyl and norfentanyl in human plasma by liquid chromatography-tandem mass spectrometry using electrospray ionization.

  2003cited by this paper
• Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.

  2003cited by this paper
• Transdermal fentanyl abuse and misuse.

  2002cited by this paper
• Fatal intravenous misuse of transdermal fentanyl

  2002cited by this paper
• Simultaneous determination of fentanyl and midazolam using high-performance liquid chromatography with ultraviolet detection.

  1999cited by this paper
• Gas chromatographic-mass spectrometry and gas chromatographic-Fourier transform infrared spectroscopy assay for the simultaneous identification of fentanyl metabolites.

  1997cited by this paper
• Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.

  1997cited by this paper
• High Performance Liquid Chromatography Microassay for the Simultaneous Determination of Fentanyl and Its Major Metabolites in Biological Samples

  1996cited by this paper
• Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.

  1996cited by this paper
• Biotransformation of tritiated fentanyl in human liver microsomes. Monitoring metabolism using phenylacetic acid and 2-phenylethanol.

  1995cited by this paper
• Fentanyl Remaining in a Transdermal System Following Three Days of Continuous Use

  1995cited by this paper
• An Analysis of the Duration of Fentanyl and Its Metabolites in Urine and Saliva

  1993cited by this paper
• Clinical uses of fentanyl, sufentanil, and alfentanil.

  1991cited by this paper
• Opioid activity and distribution of fentanyl metabolites

  1986cited by this paper
• Identification and quantitative determination of fentanyl metabolites in patients by gas chromatography--mass spectrometry.

  1984cited by this paper
• Disposition of toxic drugs and chemicals in man

  1982cited by this paper
• The assay of fentanyl and its metabolites in plasma of patients using gas chromatography with alkali flame ionisation detection and gas chromatography-mass spectrometry.

  1981cited by this paper
• Studies on the fate of fentanyl.

  1969cited by this paper

• Modern Methods for Detection of Fentanyl and Its Analogues: A Comprehensive Review of Technologies and Applications

  2025cites this paper
• Detection of Fentanyl and Fentanyl Analogs.

  2025cites this paper
• Identification of fentanyl analogs and potential biomarkers in urine using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and liquid chromatography-quadrupole/time of flight mass spectrometry (LC-Q/TOF-MS).

  2024cites this paper
• Development and Validation of a Gas Chromatography‐Mass Spectrometry Method for the Determination of Fentanyl and Butyryl Fentanyl in Oral Fluid

  2024cites this paper
• Short-cut route validated for monitoring fentanyl and its metabolite in urine using LC–MS/MS, in a wide concentration range

  2024cites this paper
• Rapid Analysis of Fentanyl and Fentanyl Analogues from Whole Blood Using SPME Coupled to the Microfluidic Open Interface.

  2023cites this paper
• Review of analytical methods for screening and quantification of fentanyl analogs and novel synthetic opioids in biological specimens

  2023cites this paper
• An Ultrasensitive Norfentanyl Sensor Based on a Carbon Nanotube-Based Field-Effect Transistor for the Detection of Fentanyl Exposure

  2023cites this paper
• Preparation of glucuronides using liver microsomes and their characterization by 1D/2D NMR spectroscopy and mass spectrometry: Application to fentanyl metabolites.

  2023cites this paper
• Suspect Screening of Fentanyl Analogs Using Matrix-Assisted Ionization and a Miniature Mass Spectrometer with a Custom Expandable Mass Spectral Library.

  2021cites this paper
• Determination of synthetic opioids in oral fluid samples using fabric phase sorptive extraction and gas chromatography-mass spectrometry.

  2021cites this paper
• Drug Testing in Addiction Medicine

  2020cites this paper
• Direct Coupling of Bio-SPME to Liquid Electron Ionization-MS/MS via a Modified Microfluidic Open Interface

  2020cites this paper
• Metabolic Pathways and Potencies of New Fentanyl Analogs

  2019cites this paper
• Ten Years of Fentanyl-like Drugs: a Technical-analytical Review

  2019cites this paper
• Studies on the in vitro and in vivo metabolism of the synthetic opioids U-51754, U-47931E, and methoxyacetylfentanyl using hyphenated high-resolution mass spectrometry

  2019cites this paper
• On-site detection of fentanyl and its derivatives by field portable nano-liquid chromatography-electron lonization-mass spectrometry (nLC-EI-MS)

  2019cites this paper
• Paper spray mass spectrometry for the direct, semi-quantitative measurement of fentanyl and norfentanyl in complex matrices.

  2018cites this paper
• Spectroscopic methods to analyze drug metabolites

  2018cites this paper
• Simultaneous quantification of fentanyl, sufentanil, cefazolin, doxapram and keto‐doxapram in plasma using liquid chromatography–tandem mass spectrometry

  2018cites this paper
• Correction to: Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review

  2018cites this paper
• Sensitive Determination of Fentanyl in Low-Volume Serum Samples by LC-MS/MS

  2018cites this paper
• Correlations between metabolism and structural elements of the alicyclic fentanyl analogs cyclopropyl fentanyl, cyclobutyl fentanyl, cyclopentyl fentanyl, cyclohexyl fentanyl and 2,2,3,3-tetramethylcyclopropyl fentanyl studied by human hepatocytes and LC-QTOF-MS

  2018cites this paper
• Postmortem Toxicology of New Synthetic Opioids

  2018cites this paper
• Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review

  2018cites this paper
• In Vitro and In Vivo Metabolite Identification Studies for the New Synthetic Opioids Acetylfentanyl, Acrylfentanyl, Furanylfentanyl, and 4-Fluoro-Isobutyrylfentanyl

  2017cites this paper
• Use of Fentanyl in Adolescents with Clinically Severe Obesity Undergoing Bariatric Surgery: A Pilot Study

  2017cites this paper
• LC-MS determination of fentanyl in human serum and application to a fentanyl transdermal delivery pharmacokinetic study.

  2017cites this paper
• Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry

  2016cites this paper
• Metabolism and Disposition of Prescription Opioids: A Review.

  2015cites this paper
• Pharmacokinetic interaction of intravenous fentanyl with ketoconazole

  2015cites this paper
• The importance of choosing the appropriate matrix to validate a bioanalytical method according to the study needs.

  2014cites this paper